These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29872404)

  • 1. Silencing of
    Lanzo A; Safratowich BD; Kudumala SR; Gallotta I; Zampi G; Di Schiavi E; Carvelli L
    Front Physiol; 2018; 9():576. PubMed ID: 29872404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.
    Carvelli L; Blakely RD; DeFelice LJ
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14192-7. PubMed ID: 18768815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine exposure during embryogenesis changes expression and function of the dopamine transporter in Caenorhabditis elegans offspring.
    Ambigapathy G; McCowan TJ; Carvelli L
    J Neurochem; 2024 Sep; 168(9):2989-2998. PubMed ID: 38960397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in
    Refai O; Aggarwal S; Cheng MH; Gichi Z; Salvino JM; Bahar I; Blakely RD; Mortensen OV
    Mol Pharmacol; 2022 Mar; 101(3):123-131. PubMed ID: 34906999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.
    Hossain M; Wickramasekara RN; Carvelli L
    Neurochem Int; 2014 Jul; 73():27-31. PubMed ID: 24161617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Lasting Epigenetic Changes in the Dopamine Transporter in Adult Animals Exposed to Amphetamine during Embryogenesis: Investigating Behavioral Effects.
    Ke T; Ambigapathy G; Ton T; Dhasarathy A; Carvelli L
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.
    Fagan RR; Kearney PJ; Luethi D; Bolden NC; Sitte HH; Emery P; Melikian HE
    Mol Psychiatry; 2021 Dec; 26(12):7793-7802. PubMed ID: 34471250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of amphetamine actions in Caenorhabditis elegans.
    Carvelli L; Matthies DS; Galli A
    Mol Pharmacol; 2010 Jul; 78(1):151-6. PubMed ID: 20410438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
    Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
    Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine induces dopamine efflux through a dopamine transporter channel.
    Kahlig KM; Binda F; Khoshbouei H; Blakely RD; McMahon DG; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3495-500. PubMed ID: 15728379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
    Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
    J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.
    Pizzo AB; Karam CS; Zhang Y; Yano H; Freyberg RJ; Karam DS; Freyberg Z; Yamamoto A; McCabe BD; Javitch JA
    Mol Psychiatry; 2013 Jul; 18(7):824-33. PubMed ID: 22710269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Wightman RM; Caron MG
    J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
    Boudanova E; Navaroli DM; Melikian HE
    Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1.
    McDonald PW; Hardie SL; Jessen TN; Carvelli L; Matthies DS; Blakely RD
    J Neurosci; 2007 Dec; 27(51):14216-27. PubMed ID: 18094261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.
    Rodriguez-Menchaca AA; Solis E; Cameron K; De Felice LJ
    Br J Pharmacol; 2012 Apr; 165(8):2749-57. PubMed ID: 22014068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.